Global Breast Cancer Diagnostic and Drug Technologies Market Growth (Status and Outlook) 2025-2031

September 2025 | 85 pages | ID: G5FC9D1577FEN
LP Information

Abstracts

According to this study, the global Breast Cancer Diagnostic and Drug Technologies market size will reach US$ 19410 million by 2031.

Breast cancer is a malignant tumor that occurs in the epithelial tissue of the breast gland.Breast Cancer Diagnostic and Drug Technologies include mammography, biopsy and so on.

United States market for Breast Cancer Diagnostic and Drug Technologies is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

China market for Breast Cancer Diagnostic and Drug Technologies is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Europe market for Breast Cancer Diagnostic and Drug Technologies is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.

Global key Breast Cancer Diagnostic and Drug Technologies players cover Abbott, Roche, BioMerieux, Becton Dickinson, GE Healthcare, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.

LPI (LP Information)' newest research report, the “Breast Cancer Diagnostic and Drug Technologies Industry Forecast” looks at past sales and reviews total world Breast Cancer Diagnostic and Drug Technologies sales in 2024, providing a comprehensive analysis by region and market sector of projected Breast Cancer Diagnostic and Drug Technologies sales for 2025 through 2031. With Breast Cancer Diagnostic and Drug Technologies sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Breast Cancer Diagnostic and Drug Technologies industry.

This Insight Report provides a comprehensive analysis of the global Breast Cancer Diagnostic and Drug Technologies landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Breast Cancer Diagnostic and Drug Technologies portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Breast Cancer Diagnostic and Drug Technologies market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Breast Cancer Diagnostic and Drug Technologies and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Breast Cancer Diagnostic and Drug Technologies.

This report presents a comprehensive overview, market shares, and growth opportunities of Breast Cancer Diagnostic and Drug Technologies market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Mammography
• Biopsy
• Other

Segmentation by Application:

• Ductal Carcinoma of Breast
• Invasive Ductal Carcinoma
• Lobular Carcinoma
• Triple Negative Breast Cancer

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Abbott
• Roche
• BioMerieux
• Becton Dickinson
• GE Healthcare
• Hologic
• Philips
• PerkinElmer
• Quest Diagnostics

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Breast Cancer Diagnostic and Drug Technologies Market Size (2020-2031)
  2.1.2 Breast Cancer Diagnostic and Drug Technologies Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Breast Cancer Diagnostic and Drug Technologies by Country/Region (2020, 2024 & 2031)
2.2 Breast Cancer Diagnostic and Drug Technologies Segment by Type
  2.2.1 Mammography
  2.2.2 Biopsy
  2.2.3 Other
2.3 Breast Cancer Diagnostic and Drug Technologies Market Size by Type
  2.3.1 Breast Cancer Diagnostic and Drug Technologies Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Type (2020-2025)
2.4 Breast Cancer Diagnostic and Drug Technologies Segment by Application
  2.4.1 Ductal Carcinoma of Breast
  2.4.2 Invasive Ductal Carcinoma
  2.4.3 Lobular Carcinoma
  2.4.4 Triple Negative Breast Cancer
2.5 Breast Cancer Diagnostic and Drug Technologies Market Size by Application
  2.5.1 Breast Cancer Diagnostic and Drug Technologies Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Application (2020-2025)

3 BREAST CANCER DIAGNOSTIC AND DRUG TECHNOLOGIES MARKET SIZE BY PLAYER

3.1 Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Player
  3.1.1 Global Breast Cancer Diagnostic and Drug Technologies Revenue by Player (2020-2025)
  3.1.2 Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Player (2020-2025)
3.2 Global Breast Cancer Diagnostic and Drug Technologies Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 BREAST CANCER DIAGNOSTIC AND DRUG TECHNOLOGIES BY REGION

4.1 Breast Cancer Diagnostic and Drug Technologies Market Size by Region (2020-2025)
4.2 Global Breast Cancer Diagnostic and Drug Technologies Annual Revenue by Country/Region (2020-2025)
4.3 Americas Breast Cancer Diagnostic and Drug Technologies Market Size Growth (2020-2025)
4.4 APAC Breast Cancer Diagnostic and Drug Technologies Market Size Growth (2020-2025)
4.5 Europe Breast Cancer Diagnostic and Drug Technologies Market Size Growth (2020-2025)
4.6 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2020-2025)
5.2 Americas Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2020-2025)
5.3 Americas Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Breast Cancer Diagnostic and Drug Technologies Market Size by Region (2020-2025)
6.2 APAC Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2020-2025)
6.3 APAC Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2020-2025)
7.2 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2020-2025)
7.3 Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies by Region (2020-2025)
8.2 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2020-2025)
8.3 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL BREAST CANCER DIAGNOSTIC AND DRUG TECHNOLOGIES MARKET FORECAST

10.1 Global Breast Cancer Diagnostic and Drug Technologies Forecast by Region (2026-2031)
  10.1.1 Global Breast Cancer Diagnostic and Drug Technologies Forecast by Region (2026-2031)
  10.1.2 Americas Breast Cancer Diagnostic and Drug Technologies Forecast
  10.1.3 APAC Breast Cancer Diagnostic and Drug Technologies Forecast
  10.1.4 Europe Breast Cancer Diagnostic and Drug Technologies Forecast
  10.1.5 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Forecast
10.2 Americas Breast Cancer Diagnostic and Drug Technologies Forecast by Country (2026-2031)
  10.2.1 United States Market Breast Cancer Diagnostic and Drug Technologies Forecast
  10.2.2 Canada Market Breast Cancer Diagnostic and Drug Technologies Forecast
  10.2.3 Mexico Market Breast Cancer Diagnostic and Drug Technologies Forecast
  10.2.4 Brazil Market Breast Cancer Diagnostic and Drug Technologies Forecast
10.3 APAC Breast Cancer Diagnostic and Drug Technologies Forecast by Region (2026-2031)
  10.3.1 China Breast Cancer Diagnostic and Drug Technologies Market Forecast
  10.3.2 Japan Market Breast Cancer Diagnostic and Drug Technologies Forecast
  10.3.3 Korea Market Breast Cancer Diagnostic and Drug Technologies Forecast
  10.3.4 Southeast Asia Market Breast Cancer Diagnostic and Drug Technologies Forecast
  10.3.5 India Market Breast Cancer Diagnostic and Drug Technologies Forecast
  10.3.6 Australia Market Breast Cancer Diagnostic and Drug Technologies Forecast
10.4 Europe Breast Cancer Diagnostic and Drug Technologies Forecast by Country (2026-2031)
  10.4.1 Germany Market Breast Cancer Diagnostic and Drug Technologies Forecast
  10.4.2 France Market Breast Cancer Diagnostic and Drug Technologies Forecast
  10.4.3 UK Market Breast Cancer Diagnostic and Drug Technologies Forecast
  10.4.4 Italy Market Breast Cancer Diagnostic and Drug Technologies Forecast
  10.4.5 Russia Market Breast Cancer Diagnostic and Drug Technologies Forecast
10.5 Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Forecast by Region (2026-2031)
  10.5.1 Egypt Market Breast Cancer Diagnostic and Drug Technologies Forecast
  10.5.2 South Africa Market Breast Cancer Diagnostic and Drug Technologies Forecast
  10.5.3 Israel Market Breast Cancer Diagnostic and Drug Technologies Forecast
  10.5.4 Turkey Market Breast Cancer Diagnostic and Drug Technologies Forecast
10.6 Global Breast Cancer Diagnostic and Drug Technologies Forecast by Type (2026-2031)
10.7 Global Breast Cancer Diagnostic and Drug Technologies Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Breast Cancer Diagnostic and Drug Technologies Forecast

11 KEY PLAYERS ANALYSIS

11.1 Abbott
  11.1.1 Abbott Company Information
  11.1.2 Abbott Breast Cancer Diagnostic and Drug Technologies Product Offered
  11.1.3 Abbott Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Abbott Main Business Overview
  11.1.5 Abbott Latest Developments
11.2 Roche
  11.2.1 Roche Company Information
  11.2.2 Roche Breast Cancer Diagnostic and Drug Technologies Product Offered
  11.2.3 Roche Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Roche Main Business Overview
  11.2.5 Roche Latest Developments
11.3 BioMerieux
  11.3.1 BioMerieux Company Information
  11.3.2 BioMerieux Breast Cancer Diagnostic and Drug Technologies Product Offered
  11.3.3 BioMerieux Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 BioMerieux Main Business Overview
  11.3.5 BioMerieux Latest Developments
11.4 Becton Dickinson
  11.4.1 Becton Dickinson Company Information
  11.4.2 Becton Dickinson Breast Cancer Diagnostic and Drug Technologies Product Offered
  11.4.3 Becton Dickinson Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Becton Dickinson Main Business Overview
  11.4.5 Becton Dickinson Latest Developments
11.5 GE Healthcare
  11.5.1 GE Healthcare Company Information
  11.5.2 GE Healthcare Breast Cancer Diagnostic and Drug Technologies Product Offered
  11.5.3 GE Healthcare Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 GE Healthcare Main Business Overview
  11.5.5 GE Healthcare Latest Developments
11.6 Hologic
  11.6.1 Hologic Company Information
  11.6.2 Hologic Breast Cancer Diagnostic and Drug Technologies Product Offered
  11.6.3 Hologic Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 Hologic Main Business Overview
  11.6.5 Hologic Latest Developments
11.7 Philips
  11.7.1 Philips Company Information
  11.7.2 Philips Breast Cancer Diagnostic and Drug Technologies Product Offered
  11.7.3 Philips Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 Philips Main Business Overview
  11.7.5 Philips Latest Developments
11.8 PerkinElmer
  11.8.1 PerkinElmer Company Information
  11.8.2 PerkinElmer Breast Cancer Diagnostic and Drug Technologies Product Offered
  11.8.3 PerkinElmer Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 PerkinElmer Main Business Overview
  11.8.5 PerkinElmer Latest Developments
11.9 Quest Diagnostics
  11.9.1 Quest Diagnostics Company Information
  11.9.2 Quest Diagnostics Breast Cancer Diagnostic and Drug Technologies Product Offered
  11.9.3 Quest Diagnostics Breast Cancer Diagnostic and Drug Technologies Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Quest Diagnostics Main Business Overview
  11.9.5 Quest Diagnostics Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Breast Cancer Diagnostic and Drug Technologies Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Breast Cancer Diagnostic and Drug Technologies Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Mammography
Table 4. Major Players of Biopsy
Table 5. Major Players of Other
Table 6. Breast Cancer Diagnostic and Drug Technologies Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 7. Global Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2020-2025) & ($ millions)
Table 8. Global Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Type (2020-2025)
Table 9. Breast Cancer Diagnostic and Drug Technologies Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 10. Global Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2020-2025) & ($ millions)
Table 11. Global Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Application (2020-2025)
Table 12. Global Breast Cancer Diagnostic and Drug Technologies Revenue by Player (2020-2025) & ($ millions)
Table 13. Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Player (2020-2025)
Table 14. Breast Cancer Diagnostic and Drug Technologies Key Players Head office and Products Offered
Table 15. Breast Cancer Diagnostic and Drug Technologies Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 16. New Products and Potential Entrants
Table 17. Mergers & Acquisitions, Expansion
Table 18. Global Breast Cancer Diagnostic and Drug Technologies Market Size by Region (2020-2025) & ($ millions)
Table 19. Global Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Region (2020-2025)
Table 20. Global Breast Cancer Diagnostic and Drug Technologies Revenue by Country/Region (2020-2025) & ($ millions)
Table 21. Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Country/Region (2020-2025)
Table 22. Americas Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2020-2025) & ($ millions)
Table 23. Americas Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Country (2020-2025)
Table 24. Americas Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2020-2025) & ($ millions)
Table 25. Americas Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Type (2020-2025)
Table 26. Americas Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2020-2025) & ($ millions)
Table 27. Americas Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Application (2020-2025)
Table 28. APAC Breast Cancer Diagnostic and Drug Technologies Market Size by Region (2020-2025) & ($ millions)
Table 29. APAC Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Region (2020-2025)
Table 30. APAC Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2020-2025) & ($ millions)
Table 31. APAC Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2020-2025) & ($ millions)
Table 32. Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Country (2020-2025) & ($ millions)
Table 33. Europe Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Country (2020-2025)
Table 34. Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2020-2025) & ($ millions)
Table 35. Europe Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2020-2025) & ($ millions)
Table 36. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Region (2020-2025) & ($ millions)
Table 37. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Type (2020-2025) & ($ millions)
Table 38. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size by Application (2020-2025) & ($ millions)
Table 39. Key Market Drivers & Growth Opportunities of Breast Cancer Diagnostic and Drug Technologies
Table 40. Key Market Challenges & Risks of Breast Cancer Diagnostic and Drug Technologies
Table 41. Key Industry Trends of Breast Cancer Diagnostic and Drug Technologies
Table 42. Global Breast Cancer Diagnostic and Drug Technologies Market Size Forecast by Region (2026-2031) & ($ millions)
Table 43. Global Breast Cancer Diagnostic and Drug Technologies Market Size Market Share Forecast by Region (2026-2031)
Table 44. Global Breast Cancer Diagnostic and Drug Technologies Market Size Forecast by Type (2026-2031) & ($ millions)
Table 45. Global Breast Cancer Diagnostic and Drug Technologies Market Size Forecast by Application (2026-2031) & ($ millions)
Table 46. Abbott Details, Company Type, Breast Cancer Diagnostic and Drug Technologies Area Served and Its Competitors
Table 47. Abbott Breast Cancer Diagnostic and Drug Technologies Product Offered
Table 48. Abbott Breast Cancer Diagnostic and Drug Technologies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 49. Abbott Main Business
Table 50. Abbott Latest Developments
Table 51. Roche Details, Company Type, Breast Cancer Diagnostic and Drug Technologies Area Served and Its Competitors
Table 52. Roche Breast Cancer Diagnostic and Drug Technologies Product Offered
Table 53. Roche Breast Cancer Diagnostic and Drug Technologies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 54. Roche Main Business
Table 55. Roche Latest Developments
Table 56. BioMerieux Details, Company Type, Breast Cancer Diagnostic and Drug Technologies Area Served and Its Competitors
Table 57. BioMerieux Breast Cancer Diagnostic and Drug Technologies Product Offered
Table 58. BioMerieux Breast Cancer Diagnostic and Drug Technologies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 59. BioMerieux Main Business
Table 60. BioMerieux Latest Developments
Table 61. Becton Dickinson Details, Company Type, Breast Cancer Diagnostic and Drug Technologies Area Served and Its Competitors
Table 62. Becton Dickinson Breast Cancer Diagnostic and Drug Technologies Product Offered
Table 63. Becton Dickinson Breast Cancer Diagnostic and Drug Technologies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 64. Becton Dickinson Main Business
Table 65. Becton Dickinson Latest Developments
Table 66. GE Healthcare Details, Company Type, Breast Cancer Diagnostic and Drug Technologies Area Served and Its Competitors
Table 67. GE Healthcare Breast Cancer Diagnostic and Drug Technologies Product Offered
Table 68. GE Healthcare Breast Cancer Diagnostic and Drug Technologies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 69. GE Healthcare Main Business
Table 70. GE Healthcare Latest Developments
Table 71. Hologic Details, Company Type, Breast Cancer Diagnostic and Drug Technologies Area Served and Its Competitors
Table 72. Hologic Breast Cancer Diagnostic and Drug Technologies Product Offered
Table 73. Hologic Breast Cancer Diagnostic and Drug Technologies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 74. Hologic Main Business
Table 75. Hologic Latest Developments
Table 76. Philips Details, Company Type, Breast Cancer Diagnostic and Drug Technologies Area Served and Its Competitors
Table 77. Philips Breast Cancer Diagnostic and Drug Technologies Product Offered
Table 78. Philips Breast Cancer Diagnostic and Drug Technologies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 79. Philips Main Business
Table 80. Philips Latest Developments
Table 81. PerkinElmer Details, Company Type, Breast Cancer Diagnostic and Drug Technologies Area Served and Its Competitors
Table 82. PerkinElmer Breast Cancer Diagnostic and Drug Technologies Product Offered
Table 83. PerkinElmer Breast Cancer Diagnostic and Drug Technologies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 84. PerkinElmer Main Business
Table 85. PerkinElmer Latest Developments
Table 86. Quest Diagnostics Details, Company Type, Breast Cancer Diagnostic and Drug Technologies Area Served and Its Competitors
Table 87. Quest Diagnostics Breast Cancer Diagnostic and Drug Technologies Product Offered
Table 88. Quest Diagnostics Breast Cancer Diagnostic and Drug Technologies Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 89. Quest Diagnostics Main Business
Table 90. Quest Diagnostics Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Breast Cancer Diagnostic and Drug Technologies Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Breast Cancer Diagnostic and Drug Technologies Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Breast Cancer Diagnostic and Drug Technologies Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Breast Cancer Diagnostic and Drug Technologies Sales Market Share by Country/Region (2024)
Figure 8. Breast Cancer Diagnostic and Drug Technologies Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Type in 2024
Figure 10. Breast Cancer Diagnostic and Drug Technologies in Ductal Carcinoma of Breast
Figure 11. Global Breast Cancer Diagnostic and Drug Technologies Market: Ductal Carcinoma of Breast (2020-2025) & ($ millions)
Figure 12. Breast Cancer Diagnostic and Drug Technologies in Invasive Ductal Carcinoma
Figure 13. Global Breast Cancer Diagnostic and Drug Technologies Market: Invasive Ductal Carcinoma (2020-2025) & ($ millions)
Figure 14. Breast Cancer Diagnostic and Drug Technologies in Lobular Carcinoma
Figure 15. Global Breast Cancer Diagnostic and Drug Technologies Market: Lobular Carcinoma (2020-2025) & ($ millions)
Figure 16. Breast Cancer Diagnostic and Drug Technologies in Triple Negative Breast Cancer
Figure 17. Global Breast Cancer Diagnostic and Drug Technologies Market: Triple Negative Breast Cancer (2020-2025) & ($ millions)
Figure 18. Global Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Application in 2024
Figure 19. Global Breast Cancer Diagnostic and Drug Technologies Revenue Market Share by Player in 2024
Figure 20. Global Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Region (2020-2025)
Figure 21. Americas Breast Cancer Diagnostic and Drug Technologies Market Size 2020-2025 ($ millions)
Figure 22. APAC Breast Cancer Diagnostic and Drug Technologies Market Size 2020-2025 ($ millions)
Figure 23. Europe Breast Cancer Diagnostic and Drug Technologies Market Size 2020-2025 ($ millions)
Figure 24. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size 2020-2025 ($ millions)
Figure 25. Americas Breast Cancer Diagnostic and Drug Technologies Value Market Share by Country in 2024
Figure 26. United States Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2020-2025 ($ millions)
Figure 27. Canada Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2020-2025 ($ millions)
Figure 28. Mexico Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2020-2025 ($ millions)
Figure 29. Brazil Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2020-2025 ($ millions)
Figure 30. APAC Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Region in 2024
Figure 31. APAC Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Type (2020-2025)
Figure 32. APAC Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Application (2020-2025)
Figure 33. China Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2020-2025 ($ millions)
Figure 34. Japan Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2020-2025 ($ millions)
Figure 35. South Korea Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2020-2025 ($ millions)
Figure 36. Southeast Asia Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2020-2025 ($ millions)
Figure 37. India Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2020-2025 ($ millions)
Figure 38. Australia Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2020-2025 ($ millions)
Figure 39. Europe Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Country in 2024
Figure 40. Europe Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Type (2020-2025)
Figure 41. Europe Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Application (2020-2025)
Figure 42. Germany Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2020-2025 ($ millions)
Figure 43. France Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2020-2025 ($ millions)
Figure 44. UK Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2020-2025 ($ millions)
Figure 45. Italy Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2020-2025 ($ millions)
Figure 46. Russia Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2020-2025 ($ millions)
Figure 47. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Region (2020-2025)
Figure 48. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Type (2020-2025)
Figure 49. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size Market Share by Application (2020-2025)
Figure 50. Egypt Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2020-2025 ($ millions)
Figure 51. South Africa Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2020-2025 ($ millions)
Figure 52. Israel Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2020-2025 ($ millions)
Figure 53. Turkey Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2020-2025 ($ millions)
Figure 54. GCC Countries Breast Cancer Diagnostic and Drug Technologies Market Size Growth 2020-2025 ($ millions)
Figure 55. Americas Breast Cancer Diagnostic and Drug Technologies Market Size 2026-2031 ($ millions)
Figure 56. APAC Breast Cancer Diagnostic and Drug Technologies Market Size 2026-2031 ($ millions)
Figure 57. Europe Breast Cancer Diagnostic and Drug Technologies Market Size 2026-2031 ($ millions)
Figure 58. Middle East & Africa Breast Cancer Diagnostic and Drug Technologies Market Size 2026-2031 ($ millions)
Figure 59. United States Breast Cancer Diagnostic and Drug Technologies Market Size 2026-2031 ($ millions)
Figure 60. Canada Breast Cancer Diagnostic and Drug Technologies Market Size 2026-2031 ($ millions)
Figure 61. Mexico Breast Cancer Diagnostic and Drug Technologies Market Size 2026-2031 ($ millions)
Figure 62. Brazil Breast Cancer Diagnostic and Drug Technologies Market Size 2026-2031 ($ millions)
Figure 63. China Breast Cancer Diagnostic and Drug Technologies Market Size 2026-2031 ($ millions)
Figure 64. Japan Breast Cancer Diagnostic and Drug Technologies Market Size 2026-2031 ($ millions)
Figure 65. Korea Breast Cancer Diagnostic and Drug Technologies Market Size 2026-2031 ($ millions)
Figure 66. Southeast Asia Breast Cancer Diagnostic and Drug Technologies Market Size 2026-2031 ($ millions)
Figure 67. India Breast Cancer Diagnostic and Drug Technologies Market Size 2026-2031 ($ millions)
Figure 68. Australia Breast Cancer Diagnostic and Drug Technologies Market Size 2026-2031 ($ millions)
Figure 69. Germany Breast Cancer Diagnostic and Drug Technologies Market Size 2026-2031 ($ millions)
Figure 70. France Breast Cancer Diagnostic and Drug Technologies Market Size 2026-2031 ($ millions)
Figure 71. UK Breast Cancer Diagnostic and Drug Technologies Market Size 2026-2031 ($ millions)
Figure 72. Italy Breast Cancer Diagnostic and Drug Technologies Market Size 2026-2031 ($ millions)
Figure 73. Russia Breast Cancer Diagnostic and Drug Technologies Market Size 2026-2031 ($ millions)
Figure 74. Egypt Breast Cancer Diagnostic and Drug Technologies Market Size 2026-2031 ($ millions)
Figure 75. South Africa Breast Cancer Diagnostic and Drug Technologies Market Size 2026-2031 ($ millions)
Figure 76. Israel Breast Cancer Diagnostic and Drug Technologies Market Size 2026-2031 ($ millions)
Figure 77. Turkey Breast Cancer Diagnostic and Drug Technologies Market Size 2026-2031 ($ millions)
Figure 78. Global Breast Cancer Diagnostic and Drug Technologies Market Size Market Share Forecast by Type (2026-2031)
Figure 79. Global Breast Cancer Diagnostic and Drug Technologies Market Size Market Share Forecast by Application (2026-2031)
Figure 80. GCC Countries Breast Cancer Diagnostic and Drug Technologies Market Size 2026-2031 ($ millions)